lack of response), defined as not achieving at least 5% weight loss 6 months after titrating to the highest tolerated dose for tirzepatide, and not achieving at least 5% weight loss after 12 weeks on the 3 mg/day dose treatment for liraglutide, aligned to the MHRA summary of product characteristics (SmPC) for the respective treatment [9, 11, 12, 24]
We make losing and maintaining weight loss easy and stress-free
Thats completely normal
[5] Patients should check with a pharmacist about potential drug interactions, particularly if taking anticoagulants like warfarin, as fluconazole can increase their effect
GHRP-2 is more potent for GH release but also elevates prolactin at higher doses, raising gynecomastia concerns
Summary Summary In summary, a triathlete or endurance athlete on a GLP-1 agonist must be very intentional about their nutrition, hydration, and training